Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis

NCT00043329 · clinicaltrials.gov ↗

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteopetrosis

Interventions

DRUG: Actimmune Registry

Sponsor

InterMune